MARTINGALE ASSET MANAGEMENT L P

Position in ENTA — Enanta Pharmaceuticals Inc

CIK 936944 BOSTON, MA

Position in ENTA

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$209,051

-$258,860 QoQ

Shares Held

16,552

-24.3% QoQ

Ownership

0.057%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2020

14 quarters on record

Voting authority Sole 28% Shared 0% None 72%

Healthcare · as of Mar 31, 2026

MARTINGALE ASSET MANAGEMENT L P holds $113,855,318 across 56 Biotechnology names. ENTA ranks #49 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	44,750	$19,982,665
2	INCY	Incyte Corp	164,646	$15,496,481
3	REGN	Regeneron Pharmaceuticals, Inc.	16,861	$13,027,483
4	JAZZ	Jazz Pharmaceuticals plc	46,721	$8,832,605
5	LGND	Ligand Pharmaceuticals Inc	17,762	$3,546,183
6	CPRX	Catalyst Pharmaceuticals, Inc.	139,535	$3,454,886
7	ALNY	Alnylam Pharmaceuticals, Inc.	10,114	$3,346,419
8	ACAD	Acadia Pharmaceuticals Inc	139,964	$3,115,598

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$209,051	16,552	-24.3%	Shares	Sole	2026-05-13
2023-06-30	$467,911	21,865	+2.3%	Shares	Sole	2023-08-11
2023-03-31	$863,960	21,364	+2.4%	Shares	Sole	2023-05-12
2022-12-31	$970,546	20,863	+21.6%	Shares	Sole	2023-02-13
2022-09-30	$889,933	17,157	+9.2%	Shares	Sole	2022-11-14
2022-06-30	$742,422	15,706	+1.9%	Shares	Sole	2022-08-11
2022-03-31	$1,096,599	15,406	+0.7%	Shares	Sole	2022-05-12
2021-12-31	$1,144,582	15,306	-49.7%	Shares	Sole	2022-02-11
2021-09-30	$1,730,318	30,458	+56.9%	Shares	Sole	2021-11-12
2021-06-30	$854,146	19,408	0.0%	Shares	Sole	2021-08-13
2021-03-31	$957,202	19,408	+7.8%	Shares	Sole	2021-05-13
2020-12-31	$758,178	18,009	-56.0%	Shares	Sole	2021-02-10
2020-09-30	$1,872,768	40,908	+321.6%	Shares	Sole	2020-11-12
2020-06-30	$487,137	9,702	—	Shares	Sole	2020-08-10
No filing history on record for this holder in this stock.